Verona Pharma

Verona Pharma is a company listed under the stock ticker I9SA (GB).

View the org chart displaying its 23 main executives

Most searched biographies at Verona Pharma

• David Zaccardelli, President and Chief Executive Officer
• James Brady, Non-Executive Director
• Lisa Deschamps, Non Executive Director

Popular executive movements at Verona Pharma

• Claire Poll, Legal Counsel, is retiring  (posted on March 4 2024).
• Andrew Fisher has joined the company as General Counsel  (posted on March 4 2024).
• Michael Austwick has joined the company as Non-Executive Director  (posted on February 2 2024).

Click here to view some more movements at Verona Pharma

Create your alert
to follow the executive moves at Verona Pharma.

Verona Pharma has 2,286 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Verona Pharma

• News & SEC Filings - Verona Pharma
• News & SEC Filings - Verona Pharma

Social media about Verona Pharma

• Verona Pharma on Wikipedia, Google News & Yahoo Finance
• Verona Pharma on LinkedIn, Twitter & YouTube

Contact by email its executives including David Zaccardelli

Call Verona Pharma at +44 207...

View the org chart

Register to receive your alert

Report an error